MU
EW icon

Mirova US’s Edwards Lifesciences EW Stock Holding History

Mirova US’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$210M Sell
2,627,315
-111,756
-4% -$9.21M 2.39% 20
2025
Q4 		$234M Sell
2,739,071
-83,021
-3% -$6.81M 2.34% 20
2025
Q3 		$219M Sell
2,822,092
-109,205
-4% -$8.53M 2.22% 20
2025
Q2 		$229M Buy
2,931,297
+1,054,301
+56% +$78.6M 2.37% 21
2025
Q1 		$136M Buy
1,876,996
+67,774
+4% +$4.85M 1.62% 24
2024
Q4 		$134M Sell
1,809,222
-53,910
-3% -$3.77M 1.61% 25
2024
Q3 		$123M Buy
1,863,132
+1,000,066
+116% +$72.7M 1.41% 26
2024
Q2 		$79.7M Buy
863,066
+17,365
+2% +$1.54M 0.99% 26
2024
Q1 		$80.8M Sell
845,701
-14,699
-2% -$1.23M 1.09% 25
2023
Q4 		$65.6M Sell
860,400
-5,150
-0.6% -$358K 0.99% 25
2023
Q3 		$60M Buy
865,550
+33,641
+4% +$2.7M 1.02% 24
2023
Q2 		$78.5M Buy
831,909
+19,816
+2% +$1.72M 1.31% 23
2023
Q1 		$67.2M Buy
812,093
+9,211
+1% +$724K 1.22% 23
2022
Q4 		$59.9M Buy
802,882
+19,423
+2% +$1.5M 1.2% 25
2022
Q3 		$64.7M Buy
+783,459
New +$75.4M 1.51% 24

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Mirova US's EW Position: Q1 2026 in Review

Mirova US reduced its Edwards Lifesciences (EW) stake by 4.1% in Q1 2026, selling an estimated $9.21M and leaving 2,627,315 shares worth $210M. The position accounts for 2.39% of the portfolio, ranked #20.

Mirova US first reported a position in EW in Q3 2022 and has held it in 15 quarters since. The position peaked at $234M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Mirova US held 2,627,315 shares of Edwards Lifesciences worth $210M as of Q1 2026.
  • Mirova US sold 111,756 Edwards Lifesciences shares in Q1 2026, an estimated $9.21M.
  • Edwards Lifesciences made up 2.39% of Mirova US's portfolio in Q1 2026, its #20 holding.
  • Mirova US first reported a position in Edwards Lifesciences in Q3 2022 and has held it in 15 quarters since.
  • Mirova US's Edwards Lifesciences position peaked at $234M in Q4 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Mirova US's 13F filing for Q1 2026, filed 11 May 2026.